Synthetic retina gives fresh view for visually impaired

The future is bright for visually impaired patients thanks to an Oxford student who has been the first to use synthetic tissue to develop an artificial retina grown in a laboratory. Published in Scientific Reports, the findings show progress in bionic implants to mimic human tissues to treat degenerative eye conditions.

Vanessa Restrepo-Schild, lead researcher and student at Oxford University, and her team developed the synthetic, double-layer retina to consists of soft water droplets and biological cell membrane proteins to mimic a human retina. The retina is able to detect and react to light and create a grey scale image.

“The synthetic material can generate electrical signals, which stimulate the neurons at the back of our eye just like the original retina,” said Restrepo-Schild.

The study showed the implant as a less invasive alternative compared to a mechanical device. Unlike current artificial retinal implant, the cell-cultures in this developed retina produced biodegradable material that did not contain foreign bodies of living entities.

“The human eye is incredibly sensitive, which is why foreign bodies like metal retinal implants can be so damaging, leading to inflammation and/or scaring,” said Restrepo-Schild. “But a biological synthetic implant is soft and water based, so much more friendly to the eye environment. I have taken the principals behind vital bodily functions, e.g. our sense of hearing, touch and the ability to detect light, and replicated them in a laboratory environment with natural, synthetic components. I hope my research is the first step in a journey towards building technology that is soft and biodegradable instead of hard and wasteful.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?